{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T13:41:32Z","timestamp":1780407692850,"version":"3.54.1"},"reference-count":12,"publisher":"Informa UK Limited","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia & Lymphoma"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.3109\/10428194.2013.779688","type":"journal-article","created":{"date-parts":[[2013,2,27]],"date-time":"2013-02-27T11:47:53Z","timestamp":1361965673000},"page":"2448-2451","source":"Crossref","is-referenced-by-count":27,"title":["Preemptive leucovorin administration minimizes pralatrexate toxicity without sacrificing efficacy"],"prefix":"10.1080","volume":"54","author":[{"given":"Ellen","family":"Koch","sequence":"first","affiliation":[{"name":"Department of Dermatology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara K.","family":"Story","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larisa J.","family":"Geskin","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2013,4,8]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.20.8470"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.2010.489552"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.29.9024"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-11-390211"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6606063"},{"key":"CIT0007","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1200\/JCO.1990.8.2.203","volume":"8","author":"Browman GP","year":"1990","journal-title":"J Clin Oncol"},{"key":"CIT0008","first-page":"1985","volume":"86","author":"Kindler HL","year":"1999","journal-title":"Sequential phase II trials by the cancer and leukemia group B. Cancer"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-06-2393"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdg099"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/84.13.1039"},{"issue":"1","key":"CIT0012","doi-asserted-by":"crossref","first-page":"4745","DOI":"10.1182\/blood.V118.21.4745.4745","volume":"118","author":"Haddad PA","year":"2011","journal-title":"Blood"},{"key":"CIT0013","first-page":"36","volume":"52","author":"Boarman DM","year":"1992","journal-title":"Cancer Res"}],"container-title":["Leukemia & Lymphoma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.3109\/10428194.2013.779688","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,22]],"date-time":"2020-07-22T22:51:00Z","timestamp":1595458260000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.3109\/10428194.2013.779688"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,8]]},"references-count":12,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2013,4,30]]},"published-print":{"date-parts":[[2013,11]]}},"alternative-id":["10.3109\/10428194.2013.779688"],"URL":"https:\/\/doi.org\/10.3109\/10428194.2013.779688","relation":{},"ISSN":["1042-8194","1029-2403"],"issn-type":[{"value":"1042-8194","type":"print"},{"value":"1029-2403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,8]]}}}